Effective August 4, 2105, Dynacare will be introducing an updated assay formulation for estradiol (E2) testing. The modified assay offers improved analytical sensitivity and a reduction of cross-reactivity. In-house studies have indicated the patient sample recovery will vary from previous results due to the new standardization and new antibodies with different cross-reactivity profiles.
Partner Update-Estradiol Testing Changes